Related Experiment Video
Updated: Aug 29, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia
Sílvia Casas1, Bálint Nagy, Erkki Elonen
1Department of Pathology, Haartman Institute, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Insights
Gene expression of HOXA9, DEK, CBL, and CSF1R was analyzed in acute myeloid leukemia (AML) patients. Aberrant expression levels correlated with specific AML subtypes and CD34 antigen status, offering potential diagnostic insights.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Aberrant gene expression of HOXA9, DEK, CBL, and CSF1R is implicated in acute myeloid leukemia (AML) pathogenesis.
- Understanding these gene expression patterns is crucial for refining AML diagnosis and prognosis.
Purpose of the Study:
- To quantify the expression levels of HOXA9, DEK, CBL, and CSF1R in adult AML patients.
- To investigate the correlation between the expression of these genes and key hematologic and clinical parameters in AML.
Main Methods:
- Quantitative real-time RT-PCR was employed to analyze gene expression in 41 adult AML patients.
- Expression levels were correlated with patient age, French-American-British (FAB) classification, immunophenotype, and karyotype aberrations.
Main Results:
- High prevalence of aberrant gene expression observed: DEK (98% overexpression), HOXA9 (78% overexpression, 15% underexpression), CBL (20% overexpression, 20% underexpression), CSF1R (17% overexpression, 42% underexpression).
- Lower HOXA9 expression was significantly associated with the t(8;21)(q22;q22) karyotype (p < 0.05).
- CD34-negative bone marrow samples correlated with DEK or HOXA9 overexpression. AML-M2 subtype showed lower CBL, CSF1R, or HOXA9 expression, while AML-M5 subtype exhibited CBL or CSF1R overexpression.
Conclusions:
- HOXA9, DEK, CBL, and CSF1R exhibit frequent aberrant expression in adult AML.
- Specific gene expression patterns are linked to distinct AML subtypes (M2, M5) and cytogenetic abnormalities (t(8;21)), suggesting their potential as biomarkers.
Abstract:
Previous gene function analyses have indicated that HOXA9, DEK, CBL and CSF1R are aberrantly expressed in acute myeloid leukemia (AML). We analyzed the expression of these genes in a series of 41 adult patients with AML using quantitative real-time RT-PCR, and tested the association of the expression with the following hematologic and clinical parameters: age, FAB, immunophenotype and karyotype aberrations. A high proportion of the patients showed over- or underexpression of the analyzed genes. DEK was overexpressed in 98% of the cases, whereas CBL, CSF1R and HOXA9 were either overexpressed in 20%, 17% and 78% or underexpressed in 20%, 42% and 15% of the cases, respectively. Patients whose karyotype contained t(8;21)(q22;q22), showed lower relative expression of HOXA9 at a statistically significant level (p < 0.05). Bone marrow samples without expression of CD34 antigen were associated with either overexpression of DEK or HOXA9. Furthermore, an association was found between the AML-M2 subtype and lower expression of CBL, CSF1R or HOXA9, and between the AML-M5 subtype and CBL or CSF1R overexpression.
Related Concept Videos
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells

